MedPath

A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Phase 2
Recruiting
Conditions
lcerative colitis or Crohn's Disease
Registration Number
JPRN-jRCT2061220065
Lead Sponsor
Yamasaki Fumie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
21
Inclusion Criteria

Diagnosis of UC or CD for >= 3 months
-Patient with moderate to severe active UC or CD
a note: Additional criteria apply

Exclusion Criteria

-Diagnosis of indeterminate colitis, ischemic colitis, radiation colitis,
diverticular disease associated with colitis, or microscopic colitis.
-Patient has colonic dysplasia or neoplasia, toxic megacolon, primary sclerosing cholangitis, known non-passable colonic stricture, presence of colonic or small bowel stoma, presence of non-passable colonic or small bowel obstruction or resection preventing the endoscopy procedure, or fulminant colitis.
a note: Additional criteria apply

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath